Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe Asthma: a Randomized Controlled Trial

NCT02124226 is registered in ClinicalTrials.gov with University of Catania as lead sponsor.

NCT NCT02124226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02124226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe Asthma: a Randomized Controlled Trial
Lead sponsor
University of Catania
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2021
Completion date
July 31, 2022
Enrollment
102 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

low dose methotrexate in severe chronic asthma